Private Equity Round - F2G

Private Equity Round - F2G

Investment Firm

Overview

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

Announced Date

Jun 20, 2016

Funding Type

Private Equity

Highlights

Location

Europe

Social

Investor Lead

Sectoral Asset Management

Sectoral Asset Management

Sectoral Asset Management is a early_stage_venture and late_stage_venture and post_ipo firm.

Participant Investors

8

Investor Name
Participant InvestorNovo Holdings
Participant InvestorMerifin Capital
Participant InvestorAisling Capital
Participant InvestorAdvent Life Sciences
Participant InvestorSunstone Life Science Ventures

Round Details and Background

F2G raised $60000000 on 2016-06-20 in Private Equity Round

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 04, 2022
Private Equity Round - F2G
2-70.0M
Jun 20, 2016
Private Equity Round - F2G
8-60.0M
Sep 05, 2012
Venture Round - F2G
7-30.0M
Aug 18, 2008
Venture Round - F2G
4-11.8M

Recent Activity

There is no recent news or activity for this profile.